| MANAGEMENT DISCUSSION AND ANALYSIS |
|
 |
|
| Domestic formulations, the sales of speciality prescription brands in India, were 55% of revenues, with 41% growth. This year, 32 products were brought to market, topping our product baskets across divisions. 11of these products used difficult technologies or had complex drug delivery technology to make them more patient-friendly. |
|
 |
 |
| (Rs. in millions) Consolidated results from 2001-02 onwards. |
|
 |
|
| CMARC's speciality list |
|
| In core therapy areas where we are ranked at number 1- psychiatry, neurology, cardiology, diabetology, ophthalmology, diabetology (a new addition to this list)- we continue to retain top rank with specialists and add market share in fairly competitive markets. In seven of the twelve therapy areas that we are present in, we rank among the top 3 companies. These rankings continue to endorse the advantage of focus on customers in specific therapy areas. Market share increase was also seen in therapy areas of relatively recent presence like gynecology and oncology. This increase in rankings is supported by strong execution on the ground, patient friendly products, and the introduction of products with technical complexity. |
|
|
|
|
|
News Articles
Contact Us
